cyclosporine and Albinism, Cutaneous

cyclosporine has been researched along with Albinism, Cutaneous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ayvaz, DC; Bayrakci, B; Kesici, S; Kuskonmaz, B; Sag, E; Tezcan, I; Uckan, D; Unal, S; Yalnızoglu, D	1

Other Studies

1 other study(ies) available for cyclosporine and Albinism, Cutaneous

Article	Year
Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab. Pediatric blood & cancer, 2014, Volume: 61, Issue:5 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Hearing Loss, Sensorineural; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Myasthenia Gravis; Mycophenolic Acid; Piebaldism; Pigmentation Disorders; Plasma Exchange; Remission Induction; Rituximab; Transplantation, Homologous; Treatment Outcome	2014

Article

Year

Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab.

Pediatric blood & cancer, 2014, Volume: 61, Issue:5

Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Hearing Loss, Sensorineural; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Myasthenia Gravis; Mycophenolic Acid; Piebaldism; Pigmentation Disorders; Plasma Exchange; Remission Induction; Rituximab; Transplantation, Homologous; Treatment Outcome

2014